Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Diagnostic Device Evaluation - What are Clinically Relevant Determinants?

Krummenauer F.1, Troost A.2
1Department of Medical Biometry, Epidemiology and Informatics, 2University Eye Hospital, Medical School, University of Mainz

Purpose: The demand for minimum invasive, but maximum valid and reliable diagnostic strategies catalyses increasing development of diagnostic devices in ophthalmology. Reductions in patient exposure can often be combined with a gain in diagnostic validity and / or reliability compared to previously established diagnostic standards. However, to substitute a diagnostic standard device by a diagnostic novelty, its diagnostic non-inferiority has to be proven in advance by means of biostatistical evaluation. Unfortunately, study reports and publications on diagnostic device comparisons do not always provide appropriate determinants of validity and reliability, but draw conclusions from rather subinformative measures.
Method: A valid biostatistical evaluation of a diagnostic novelty must not only concentrate on median agreement measures, but also consider the devices' measurement precisions and reliabilities. In general, one has to consider the scale level of the underlying data in addition: Are diagnostic findings of interest ("positive / negative finding") or rather continuous measurement values?. A check list for clinical authors will be provided, which summarizes flexible means for reporting device comparison trials; it will be illustrated by the result presentation of a recent trial on the comparison o


Zurück | Back